Psilocin crystalline forms
AssigneeTRYP Therapeutics Inc.
InventorsJim GILLIGAN, Peter GUZZO
Life of this patent
Estimating the term…
Abstract
The present invention relates to crystalline forms of psilocin (4-hydroxy-N,N-dimethyltryptamine) salts or cocrystals, as well as compositions, methods of preparation and methods of their use. The present invention also relates to said crystalline forms having improved physical properties such as aqueous solubility and stability, wherein the crystalline forms and compositions thereof are suitable for oral, subcutaneous, intravenous, or intramuscular administration.
Claims15
-39. (canceled)
A crystalline form of a pharmaceutically acceptable salt of psilocin (4-hydroxy-N,N-dimethyltryptamine), wherein the crystalline form is Besylate Form A and exhibits XRPD (X-ray power diffraction) peaks at about 15.44° 2θ±0.20, or about 18.33° 2θ0.20, or about 25.41° 2θ±0.20.
Dependencies are inferred from the claim text.